8 cannabis investors share their outlook on the European market in H1 2022
TechCrunch
APRIL 13, 2022
While valuations are trending up, Germany’s exciting market developments still require business leaders to perform and scale. Note that doctors in Europe can only prescribe a finished product to patients, unlike the U.S., How are these issues informing your advice to your cannabis-related portfolio companies? As in the U.S.,
98 
Let's personalize your content